Effectiveness of Circulating DNA for Predicting the Relapse and Overall Survival in NHL Patients
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Diffuse Large B Cell Lymphoma
Related studies linked through entity extraction aliases.
Blinatumomab Consolidation Post Autologous Stem Cell Transplantation in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
- Status
- COMPLETED
- Phase
- PHASE1
Safety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid Cancers
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor Patients
- Status
- COMPLETED
- Phase
- PHASE1
Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL
- Status
- COMPLETED
- Phase
- PHASE1
Open-Label, Multi-Center, Two-Part, Ph1 Study to Characterize the PKs of an Intravenous Micro-Dose of [14C]-Tazemetostat (EPZ 6438) and the ADME of an Oral [14C]-Labeled Dose of Tazemetostat in Subjects With B-Cell Lymphomas or Adv Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
The Value and Mechanisms for Monocytes Subpopulations in Predicting the Prognosis of Lymphomas
- Status
- UNKNOWN
- Phase
- N/A
HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life
- Status
- UNKNOWN
- Phase
- N/A
Study of Safety,Efficacy and Pharmacokinetics of CT-1530 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
RICE-ibrutinib in Relapsed DLBCL
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Decitabine Plus R-CHOP in Diffuse Large B-cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Role of CX3CR1-expressing Cells in Hematologic Malignancy
- Status
- UNKNOWN
- Phase
- N/A
A Study Comparing the Efficiency and Safety of S-CHOP(Cyclophosphamide, Hydroxydaunomycin, Oncovin, and Prednisone) Versus R-CHOP in Untreated CD20(Cluster of Differentiation Antigen 20)-Positive DLBCL Patients
- Status
- UNKNOWN
- Phase
- PHASE3
Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
CyBeR Association in Relapsed/Refractory DLBCL
- Status
- UNKNOWN
- Phase
- PHASE2
A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Bendamustine Plus Subcutaneous Rituximab in Patients With Diffuse Large B-cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggressive BCL
- Status
- UNKNOWN
- Phase
- PHASE2
Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001)
- Status
- COMPLETED
- Phase
- PHASE1